Get the Stockscreener App
0.00
100.00%
-0.6063
After Hours:
.50
0.50
+
23 Andme Holding Co stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$0.6063
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$82.91M
Revenue:
$247.99M
Net Income/Loss:
$-521.97M
P/E Ratio:
0.00
EPS:
-1.11
Net Cash Flow:
$-194.28M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$12.40
23 Andme Holding Co Stock (ME) Company Profile
Name
23 Andme Holding Co
Sector
Industry
Phone
(650) 938-6300
Address
223 N. MATHILDA AVE., SUNNYVALE
Compare ME with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
0.00 | 82.91M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
404.93 | 155.07B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
190.95 | 139.43B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
511.99 | 39.41B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
112.40 | 30.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
140.43 | 26.52B | 15.50B | 1.33B | 2.16B | 7.34 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-22 | Initiated | Berenberg | Buy |
| Sep-22-22 | Initiated | Cowen | Outperform |
| Nov-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Jul-12-21 | Initiated | Citigroup | Buy |
23 Andme Holding Co Stock (ME) Latest News
Do you have 23andMe? You may get cash back in 23andMe data settlement. Here's how - Bergen Record
Rite Aid Back In Ch. 11, Tupperware Gets OK To Liquidate - Law360
23andMe DNA Data Sale In Ch. 11 Tests Ombudsmen's Reach - Law360
23andMe Claims Related to Bankruptcy Filing: Deadlines and How to File - TODAY.com
23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14 - TechCrunch
23andMe Gets WashU Law Prof For Privacy Ombudsman - Law360
23andMe Expects Multiple Bids for Genetic Data, Lawyer Says - Mint
23andMe Gets Privacy Watchdog, Yellow Investors Push Ch. 7 - Law360
UK user data must be protected during 23andMe bankruptcy, watchdog says - MSN
23andMe users’ genetic data is at risk, state AGs warn - Idaho Capital Sun
23andMe Says 1.3M Customers Have Asked To Delete Data - Law360
23andMe Agrees To Privacy Ombudsman In Ch. 11 - Law360
23andMe will have court-appointed overseer for genetic data in bankruptcy - marketscreener.com
23andMe Agrees to Back a Privacy Advocate for Customer DNA Data - Bloomberg
23andMe bankruptcy bid deadline extended as DNA privacy woes linger - SiliconValley.com
23andMe Bankruptcy Bid Deadline Extended as DNA Privacy Woes Linger - Bloomberg.com
Imerys Ch. 11 Trial Abruptly Paused, Celsius Seeks Sanctions - Law360
23andMe requiring potential bidders to affirm they will uphold data privacy - Seeking Alpha
23andMe Data Breach Class Asks Bankruptcy Court for Group Claim - Bloomberg Law News
23andMe Goes Bankrupt as Only 550,000 Subscribe to Gene Testing - MSN
23andMe Has Received 'Significant Interest' In Ch. 11 Auction - Law360
23andMe bankruptcy sale may need national security review - Reuters
23andMe Ch. 11 Sale Sparks DNA Privacy Oversight Battle - Law360
23andMe Provides Update Regarding Court-Supervised Sale Process - The Manila Times
US says 23andMe deal could prompt national security review - The Edge Malaysia
US Says 23andMe Deal Could Prompt National Security Review - Bloomberg
Data Breach, Market Challenges Led 23andMe To Ch. 11 - Law360
Lawmakers launch investigation into 23andMe after bankruptcy - Yahoo News UK
23andMe Faces House Panel Query Over Customer Data - marketscreener.com
Bankrupt 23andMe Needs Security Examiner for Data, 27 States Say - Bloomberg Law News
US House committee seeks testimony from 23andMe co-founder after bankruptcy - Reuters
Competing plans to handle 23andMe genetic data could come to a head in bankruptcy court - The Business Journals
Here's What Potential 23andMe Buyers Could Do With Your Genetic Data - Business Insider
Under The Radar: Bankruptcy News You May Have Missed - Law360
23andMe Asks For Independent Customer Data Rep In Ch. 11 - Law360
Kelley Drye Selected as Counsel to the Official Committee of Unsecured Creditors of 23andMe - Kelley Drye & Warren LLP
Bankrupt 23andMe Seeks Independent Rep to Ease DNA Sale Fears - Bloomberg Law News
What Happens to Your Personal Data When a Company Folds? - MSN
23andMe filed for bankruptcy. What’s going to happen to your DNA data? - Fort Worth Star-Telegram
Luke O’Neill: Why genetic testing company 23andMe is bankrupt - Newstalk
Charles Schwab Investment Management Inc. Sells 254,034 Shares of 23andMe Holding Co. (NASDAQ:ME) - Defense World
Fortune Tech: All-out panic - Fortune
FTC eyeing 23andme’s disposition of genomic data - BioWorld MedTech
Decoding 23andMe’s downfall - Chemistry World
FTC wants to ensure 23andMe customers personal data protected - Seeking Alpha
FTC concerned about privacy protections in 23andMe bankruptcy - Reuters
FTC Raises Concerns Over Sale of Data in 23 and Me Bankruptcy - Bloomberg Law News
FTC Chief Stresses Importance of 23andMe Privacy Protections in Bankruptcy - MarketScreener
23 Andme Holding Co Stock (ME) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.28%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):